Reply Elimination of All Inducible Ventricular Tachycardias as the Endpoint for Ablation

Miki Yokokawa; Hyungjin Myra Kim; Kazim Baser; William Stevenson; Koichi Nagashima; Paolo Della Bella; Pasquale Vergara; Gerhard Hindricks; Arash Arya; Katja Zeppenfeld; Marta De Riva Silva; Emile G. Daoud; Sunil Kumar; Karl Heinz Kuck; Roland Tilz; Shibu Mathew; Hamid Ghanbari; Rakesh Latchamsetty; Fred Morady; Frank Bogun

doi:10.1016/j.jacc.2015.09.066

Reply Elimination of All Inducible Ventricular Tachycardias as the Endpoint for Ablation

Miki Yokokawa, Hyungjin Myra Kim, Kazim Baser, William Stevenson, Koichi Nagashima, Paolo Della Bella, Pasquale Vergara, Gerhard Hindricks, Arash Arya, Katja Zeppenfeld, Marta De Riva Silva, Emile G. Daoud, Sunil Kumar, Karl Heinz Kuck, Roland Tilz, Shibu Mathew, Hamid Ghanbari, Rakesh Latchamsetty, Fred Morady, Frank Bogun^*

^*Corresponding author for this work

Clinic of Internal Medicine II - Cardiology

Division of Cardiology

Original language	English
Journal	Journal of the American College of Cardiology
Volume	66
Issue number	22
Pages (from-to)	2576-2577
Number of pages	2
ISSN	0735-1097
DOIs	https://doi.org/10.1016/j.jacc.2015.09.066
Publication status	Published - 2015

Funding

Please note: Dr. Bogun has received funding from the LeDucq Foundation. Dr. Stevenson is coholder of a patent for needle ablation that is consigned to Brigham and Women's Hospital. Dr. Tilz has received research grants from Hansen Medical and St. Jude Medical; has received travel grants from St. Jude Medical, Biosense Webster, and Daiichi-Sankyo; and has received lecture fees from St. Jude Medical, Biosense Webster, Biotronik, Topera, Pfizer, Bristol-Myers Squibb, Bayer, and Sanofi. Dr. Kuck has received relevant research grants, consultant fees, and honoraria from Biosense Webster, Stereotaxis, Medtronic, St. Jude Medical, and Biotronik. All other authors have reported that they have no relationships relevant to the contents of this paper.

Research Areas and Centers

Centers: Cardiological Center Luebeck (UHZL)

DFG Research Classification Scheme

2.22-12 Cardiology, Angiology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jacc.2015.09.066

Cite this

Yokokawa, M., Kim, H. M., Baser, K., Stevenson, W., Nagashima, K., Della Bella, P., Vergara, P., Hindricks, G., Arya, A., Zeppenfeld, K., De Riva Silva, M., Daoud, E. G., Kumar, S., Kuck, K. H., Tilz, R., Mathew, S., Ghanbari, H., Latchamsetty, R., Morady, F., & Bogun, F. (2015). Reply Elimination of All Inducible Ventricular Tachycardias as the Endpoint for Ablation. Journal of the American College of Cardiology, 66(22), 2576-2577. https://doi.org/10.1016/j.jacc.2015.09.066

@article{c039a89534b24b4aac73e96a19debf70,

title = "Reply Elimination of All Inducible Ventricular Tachycardias as the Endpoint for Ablation",

author = "Miki Yokokawa and Kim, \{Hyungjin Myra\} and Kazim Baser and William Stevenson and Koichi Nagashima and \{Della Bella\}, Paolo and Pasquale Vergara and Gerhard Hindricks and Arash Arya and Katja Zeppenfeld and \{De Riva Silva\}, Marta and Daoud, \{Emile G.\} and Sunil Kumar and Kuck, \{Karl Heinz\} and Roland Tilz and Shibu Mathew and Hamid Ghanbari and Rakesh Latchamsetty and Fred Morady and Frank Bogun",

note = "Funding Information: Please note: Dr. Bogun has received funding from the LeDucq Foundation. Dr. Stevenson is coholder of a patent for needle ablation that is consigned to Brigham and Women's Hospital. Dr. Tilz has received research grants from Hansen Medical and St. Jude Medical; has received travel grants from St. Jude Medical, Biosense Webster, and Daiichi-Sankyo; and has received lecture fees from St. Jude Medical, Biosense Webster, Biotronik, Topera, Pfizer, Bristol-Myers Squibb, Bayer, and Sanofi. Dr. Kuck has received relevant research grants, consultant fees, and honoraria from Biosense Webster, Stereotaxis, Medtronic, St. Jude Medical, and Biotronik. All other authors have reported that they have no relationships relevant to the contents of this paper. ",

year = "2015",

doi = "10.1016/j.jacc.2015.09.066",

language = "English",

volume = "66",

pages = "2576--2577",

journal = "Journal of the American College of Cardiology",

issn = "0735-1097",

publisher = "Elsevier Inc.",

number = "22",

}

Yokokawa, M, Kim, HM, Baser, K, Stevenson, W, Nagashima, K, Della Bella, P, Vergara, P, Hindricks, G, Arya, A, Zeppenfeld, K, De Riva Silva, M, Daoud, EG, Kumar, S, Kuck, KH, Tilz, R, Mathew, S, Ghanbari, H, Latchamsetty, R, Morady, F & Bogun, F 2015, 'Reply Elimination of All Inducible Ventricular Tachycardias as the Endpoint for Ablation', Journal of the American College of Cardiology, vol. 66, no. 22, pp. 2576-2577. https://doi.org/10.1016/j.jacc.2015.09.066

TY - JOUR

T1 - Reply Elimination of All Inducible Ventricular Tachycardias as the Endpoint for Ablation

AU - Yokokawa, Miki

AU - Kim, Hyungjin Myra

AU - Baser, Kazim

AU - Stevenson, William

AU - Nagashima, Koichi

AU - Della Bella, Paolo

AU - Vergara, Pasquale

AU - Hindricks, Gerhard

AU - Arya, Arash

AU - Zeppenfeld, Katja

AU - De Riva Silva, Marta

AU - Daoud, Emile G.

AU - Kumar, Sunil

AU - Kuck, Karl Heinz

AU - Tilz, Roland

AU - Mathew, Shibu

AU - Ghanbari, Hamid

AU - Latchamsetty, Rakesh

AU - Morady, Fred

AU - Bogun, Frank

N1 - Funding Information: Please note: Dr. Bogun has received funding from the LeDucq Foundation. Dr. Stevenson is coholder of a patent for needle ablation that is consigned to Brigham and Women's Hospital. Dr. Tilz has received research grants from Hansen Medical and St. Jude Medical; has received travel grants from St. Jude Medical, Biosense Webster, and Daiichi-Sankyo; and has received lecture fees from St. Jude Medical, Biosense Webster, Biotronik, Topera, Pfizer, Bristol-Myers Squibb, Bayer, and Sanofi. Dr. Kuck has received relevant research grants, consultant fees, and honoraria from Biosense Webster, Stereotaxis, Medtronic, St. Jude Medical, and Biotronik. All other authors have reported that they have no relationships relevant to the contents of this paper.

PY - 2015

Y1 - 2015

UR - https://www.scopus.com/pages/publications/84962318121

U2 - 10.1016/j.jacc.2015.09.066

DO - 10.1016/j.jacc.2015.09.066

M3 - Letters

C2 - 26653638

AN - SCOPUS:84962318121

SN - 0735-1097

VL - 66

SP - 2576

EP - 2577

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

IS - 22

ER -

Reply Elimination of All Inducible Ventricular Tachycardias as the Endpoint for Ablation

Funding

Research Areas and Centers

DFG Research Classification Scheme

UN SDGs

Access to Document

Other files and links

Cite this